Pharmaceutical Technology14 天
Cetuximab biosimilar by Dragonboat Biopharmaceutical (Shanghai) for Penile Cancer ...
Cetuximab biosimilar is under clinical development by Dragonboat Biopharmaceutical (Shanghai) and currently in Phase I for Penile Cancer. According to GlobalData, Phase I drugs for Penile Cancer does ...
Medscape13 年
Cetuximab in the Treatment of Squamous Cell Carcinoma of the Head and Neck
The infusion rate should be reduced by 50% in case of nonserious infusion reactions In patients who develop serious infusion reactions, cetuximab should be discontinued immediately and permanently ...